<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of microbiology, epidemiology and immunobiology</journal-id><journal-title-group><journal-title xml:lang="en">Journal of microbiology, epidemiology and immunobiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Журнал микробиологии, эпидемиологии и иммунобиологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0372-9311</issn><issn publication-format="electronic">2686-7613</issn><publisher><publisher-name xml:lang="en">Central Research Institute for Epidemiology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">437</article-id><article-id pub-id-type="doi">10.36233/0372-9311-2019-4-82-89</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Varicella Zoster virus infection: immunity, diagnosis and modelling <italic>in vivo</italic></article-title><trans-title-group xml:lang="ru"><trans-title>Varicella Zoster-вирусная инфекция: иммунитет, диагностика и моделирование in vivo</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lavrov</surname><given-names>V. F.</given-names></name><name xml:lang="ru"><surname>Лавров</surname><given-names>В. Ф.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Лавров Вячеслав Федорович, проф.</p><p>115088, Москва, ул. 1 Дубровская, 15, стр.1, р.т. (495)674-55-01</p></bio><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Svitich</surname><given-names>O. A.</given-names></name><name xml:lang="ru"><surname>Свитич</surname><given-names>О. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kazanova</surname><given-names>A. S.</given-names></name><name xml:lang="ru"><surname>Казанова</surname><given-names>А. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kinkulkina</surname><given-names>A. R.</given-names></name><name xml:lang="ru"><surname>Кинкулькина</surname><given-names>А. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zverev</surname><given-names>V. V.</given-names></name><name xml:lang="ru"><surname>Зверев</surname><given-names>В. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Mechnikov Research Institute of Vaccines and Serа</institution></aff><aff><institution xml:lang="ru">НИИ вакцин и сывороток им. И.И.Мечникова</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Russian Medical Academy of Continuous Professional Education</institution></aff><aff><institution xml:lang="ru">Российская медицинская академия непрерывного профессионального образования</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Russian Medical Academy of Continuous Professional Education</institution></aff><aff><institution xml:lang="ru">НИИ вакцин и сывороток им. И.И.Мечникова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2019-09-02" publication-format="electronic"><day>02</day><month>09</month><year>2019</year></pub-date><volume>96</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>82</fpage><lpage>89</lpage><history><date date-type="received" iso-8601-date="2019-09-02"><day>02</day><month>09</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-09-02"><day>02</day><month>09</month><year>2019</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2019, Lavrov V.F., Svitich O.A., Kazanova A.S., Kinkulkina A.R., Zverev V.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2019, Лавров В.Ф., Свитич О.А., Казанова А.С., Кинкулькина А.Р., Зверев В.В.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="en">Lavrov V.F., Svitich O.A., Kazanova A.S., Kinkulkina A.R., Zverev V.V.</copyright-holder><copyright-holder xml:lang="ru">Лавров В.Ф., Свитич О.А., Казанова А.С., Кинкулькина А.Р., Зверев В.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://microbiol.crie.ru/jour/article/view/437">https://microbiol.crie.ru/jour/article/view/437</self-uri><abstract xml:lang="en"><p>Varicella Zoster Virus (VZV) is a highly contagious viral agent of the Herpesviridae family, which has a strict species specificity, and causes two different diseases — chickenpox, mainly in children, and herpes zoster — more often in the elderly. Obtaining additional information about the life cycle of the virus, its biology, pathogenetic features of the complications caused by it, will contribute to the emergence of more advanced methods of diagnosis and prevention, the development of new experimental approaches that allow to study the innate and adaptive mechanisms of immune protection in VZV-infection.</p></abstract><trans-abstract xml:lang="ru"><p>Varicella Zoster Virus (VZV) — высоко контагиозный вирусный агент семейства Herpesviridae, обладающий строгой видовой специфичностью и вызывающий два различных заболевания — ветряную оспу, преимущественно у детей, и опоясывающий герпес — чаще у пожилых людей. Получение дополнительных сведений о жизненном цикле вируса, его биологии, патогенетических особенностях вызываемых им осложнений будет способствовать появлению более совершенных методов диагностики и профилактики, разработке новых экспериментальных подходов, позволяющих изучать врожденные и адаптивные механизмы иммунной защиты при VZV-инфекции.</p></trans-abstract><kwd-group xml:lang="en"><kwd>VZV infection</kwd><kwd>chickenpox</kwd><kwd>herpes zoster</kwd><kwd>innate immunity</kwd><kwd>diagnosis</kwd><kwd>simulation of infection <italic>in vivo</italic></kwd></kwd-group><kwd-group xml:lang="ru"><kwd>VZV-инфекция</kwd><kwd>ветряная оспа</kwd><kwd>опоясывающий герпес</kwd><kwd>врожденный иммунитет</kwd><kwd>диагностика</kwd><kwd>моделирование инфекции in vivo</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Ганковская О.А., Бахарева И.В., Ганковская Л.В. Исследование экспрессии генов TLR9, NF-КB, ФНОα в клетках слизистой цервикального канала беременных с герпесвирусной инфекцией. Журн. микробиол. 2009, 2: 61-64.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Григорьева О.Ю. Роль TLR9 в противогерпетическом иммунитете. Влияние науки на инновационное развитие. Сборник статей международной научно-практической конференции. 2017, 2: 7-9.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Казанова А.С., Лавров В.Ф., Зверев В.В. Вирус varicella zoster и заболевания сосудов центральной нервной системы. Журн. микробиол. 2015, 3: 106-116.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. Казанова А.С., Лавров В.Ф., Дубоделов Д.В. и др. Ветряная оспа и опоясывающий лишай: история и перспективы вакцинопрофилактики. Эпидемиология и инфекционные болезни. Актуальные вопросы. 2011, 2: 36-39.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. Лавров В.Ф., Казанова А.С., Кузин С.Н. и др. Ветряная оспа и опоясывающий лишай: особенности заболеваемости и клинических проявлений. Эпидемиология и инфекционные болезни. Актуальные вопросы, 2011, 3: 54-58.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6. Aronson P.L., Lyons T.W., Cruz A. Impact of Enteroviral Polymerase Chain Reaction Testing on Length of Stay for Infants 60 Days Old or Younger. J. Pediatr. 2017, 189: 169-174.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7. Depledge D.P., Kundu S.Т., Jensen N.J. et al. Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans. Mol Biol Evol. 2014, 31(2): 397-409.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8. Elwee M.N., Vijayakrishnan S.N., Rixon F et al. Structure of the herpes simplex virus portal-vertex. PLoSBiol. 2018, 16(6): 526-535.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9. Galassi G.N., Genovese M.N., Meacci M. et al. Comment on ischemic stroke after herpes zoster. J Med Virol. 2018, 5(6): 167-175.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10. Gershon A.A., Gershon M.D. Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiol Rev. 2013, 26(4): 728-743.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11. L’Huillier A.G., Ferry T., Courvoisier D.S. et al. Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody levels and avidity. HIV Med. 2012, 13(1): 54-61.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12. Kanbayashi Y.N., Matsumoto Y.N. Predicting risk factors for varicella zoster virus infection and posthe rpetic neuralgia after hematopoietic cell transplantation using ordered logistic regression analysis. Ann Hematol. 2017, 96(2): 311-315.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13. Kim S.K., Kim M.C., Han S.B. et al. Clinical characteristics and outcomes of varicella zoster virus infection in children with hematologic malignancies in the acyclovir era. Blood Res. 2016, 51(4): 249-255.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14. Kennedy P.G., Rovnak J.N., Badani H. et al. A comparison of herpes simplex virus type 1 and varicellazoster virus latency and reactivation. J. Gen. Virol. 2015, 96(7): 1581-1602.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15. Komadina N.N., McVernon J.N., Hall R. et al. A historical perspective of influenza A(H1N2) virus. Emerg. Infect. Dis. 2014, 20(1): 6-12.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16. Kovalchuk L.V., Gankovskaya L.V., Gankovskaya O.A., Lavrov V.F. et al. Herpes simplex virus: treatment with antimicrobial peptides. Advancesin Experimental Medicine and Biology. 2007, 601: 369-376.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17. Li Y., Zhu B. et al. Genotyping of clinical varicella-zoster virus isolates collected from Yunnan in Southwestern China. Biomed Rep. 2016, 4(2): 209-214.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18. Mathew T., Thomas K., Shivde S. et al. Post herpes zoster infection neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2017, 18: 93-94.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19. Norberg P., Depledge D.P., Kundu S. et al. Recombination of Globally Circulating Varicella-Zoster Virus. Depledge. J Virol. 2015, 89(14): 7133-7146.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>20. Ojha R.P., Stallings-Smith S., Aviles-Robles M.J. et al. Incidence and case fatality of varicella zoster virus infection among pediatriccancer patients in developing countries. Eur J Pediatr. 2016, 175(4): 581-586.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>21. Park S.Y., Kim J.Y., Kim J.A. et al. Diagnostic Usefulness of Varicella-Zoster Virus Real-Time Polymerase Chain Reaction Analysis of DNA in Saliva and Plasma Specimens From Patients With Herpes Zoster. J Infect Dis. 2017, 217(1): 51-57.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>22. Suenaga T., Matsumoto M., Arisawa F. et al. Sialic Acid on Varicella-Zoster Virus Glycoprotein B Are Required for Cell-Cell Fusion. J Biol Chem. 2015, 290(32): 19833-19843.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>23. Sauerbrei A. Diagnosis, antiviral therapy and prophylaxis of varicella-zoster virus infections. Eur J Clin Microbiol Infect Dis. 2016, 35(5): 723-734.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>24. Science M., MacGregor D., Richardson S.E. et al. Central nervous system complications of varicellazoster virus. J Pediatr. 2014, 165(4): 779-785.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>25. Svitich O.A., Gankovskaya L.V., Lavrov V.F. Herpes simplex virus type 2 infection during pregnancy is correlated with elevated TLR9 and TNFα expression in cervical cells. International Trends in Immunity. 2014, 2(1): 62-66.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>26. Weller T.H. Intradermal vaccination against influenza. N Engl J Med. 2005, 352(10): 1044-1046.</mixed-citation></ref></ref-list></back></article>
